Tech Company Financing Transactions
Avitide Funding Round
Avitide closed a $4 million funding round on 1/3/2018. Investors included private investors.
Transaction Overview
Company Name
Announced On
1/3/2018
Transaction Type
Venture Equity
Amount
$3,999,983
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 3 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
16 Cavendish Ct.
Lebanon, NH 03766
USA
Lebanon, NH 03766
USA
Phone
Website
Email Address
Overview
Avitide develops customized biopharmaceutical affinity purification products with an industry-leading discovery and development service time.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Tillman Gerngross
Chief Executive Officer
Kevin Isett
Chief Financial Officer
Scott Kennedy
Chief Scientific Officer
Warren Kett
VP - Bus. Development
Daniel Freymeyer
VP - Engineering
Karol Lacki
VP - General Counsel
Kimberly Cornwell
VP - Manufacturing
Grant Espie
Browse more venture capital transactions:
Prev: 1/3/2018: DNAnexus venture capital transaction
Next: 1/3/2018: Centrexion Therapeutics venture capital transaction
Share this article
News on VC Transactions
We do our best to report on every notable VC transaction. VC transactions on this site are sourced from company press releases and news coverage. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs